INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Implications Of FDA’s Final Guidance On Informed Consent
Watch this presentation for actionable insights to enhance the clarity, simplicity, and transparency of informed consent forms, ultimately improving participant experience and understanding.
-
6 Ways Sponsors & CROs Are Optimizing Site Performance
See how Florence’s Site Enablement Platform works to overcome common trial hurdles and improve clinical trial operations, accelerate studies, and streamline compliance.
-
Global CRO Streamlines Study Startup By Centralizing IRB Review
See how PRA Health Sciences was able to convert to a central IRB to improve the overall study startup processes and timelines.
-
From Phase I In Australia To A Global Phase III
With some help, see how one California-based biotech company was able to get its patients on treatment by the end of the fiscal year and identify additional opportunities to streamline processes and leverage document/process standards.
-
The Criticality Of CMO Selection For Small Biopharma Companies10/29/2023
Delve into the criteria that small or early-stage biopharma companies should consider during their CMO selection process, along with key considerations to keep in mind.
-
Sponsors Are Selecting Fewer Clinical Research Sites: Here’s How To Be One Of Them7/14/2022
Discover why clinical trial sponsors and CROs are moving away from the traditional approach of working with a large number of trial sites and are instead concentrating on investing more time and money in fewer, select sites.
-
Advantages Of Robotic Aseptic Processing10/6/2023
Examine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
Expert Consulting And MRCT Strategy Rescues Oncology Program1/3/2024
Uncover how this strategic approach yielded significant outcomes, including uncovering missing data through IB review, streamlining dosing timelines, and achieving successful recruitment milestones.
-
Webinar: Reimbursement Methods For Sustainable CGT Business Models10/10/2023
Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Our talented and experienced team can assist in all Clinical Study Phases (Phase 0, I, II and III) and in study designs ranging from First in Human (FIH), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), Food Effect as well as Special Population studies.
-
We are manufacturing, packaging, and supply chain experts, harnessing experience and expertise to deliver you a seamless solution with the ultimate aim of improving the lives of patients.
-
Our comprehensive service eliminates the burden on sites and patients to handle travel and lodging arrangements while guaranteeing upfront coverage of all expenses.
-
Biorasi solves the problem of patient access and engagement with data empowered insights and operational excellence, delivering faster, higher quality trials.
-
Ready to make your research altogether better? Learn how Advarra® is assisting clients to reduce risk and ensure adherence to good manufacturing practice (GMP), good laboratory practice (GLP), and good tissue practice (GTP) standards.